1. Zhang, Junjie, Dong, Yang, Shi, Zhenduo, Han, Conghui, Hao, Lin. 2022. P3H4 and PLOD1 expression associates with poor prognosis in bladder cancer. In Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico, 24, 1524-1532. doi:10.1007/s12094-022-02791-1. https://pubmed.ncbi.nlm.nih.gov/35149972/
2. Fang, Chen, Liang, Yingkuan, Huang, Yong, Jiang, Wei, Feng, Yu. 2022. P3H4 Promotes Malignant Progression of Lung Adenocarcinoma via Interaction with EGFR. In Cancers, 14, . doi:10.3390/cancers14133243. https://pubmed.ncbi.nlm.nih.gov/35805016/
3. Hao, Lin, Pang, Kun, Pang, Hui, Shi, Zhenduo, Han, Conghui. 2020. Knockdown of P3H4 inhibits proliferation and invasion of bladder cancer. In Aging, 12, 2156-2168. doi:10.18632/aging.102732. https://pubmed.ncbi.nlm.nih.gov/32018225/
4. Jin, Xiangfeng, Zhou, Haiqing, Song, Jianfang, Luo, Yiren, Jiang, Haiping. 2021. P3H4 Overexpression Serves as a Prognostic Factor in Lung Adenocarcinoma. In Computational and mathematical methods in medicine, 2021, 9971353. doi:10.1155/2021/9971353. https://pubmed.ncbi.nlm.nih.gov/34257701/
5. Li, Wangjian, Ye, Lihong, Chen, Yongliang, Chen, Peng. 2018. P3H4 is correlated with clinicopathological features and prognosis in bladder cancer. In World journal of surgical oncology, 16, 206. doi:10.1186/s12957-018-1507-2. https://pubmed.ncbi.nlm.nih.gov/30322400/
6. Fang, Dengpan, He, Yuanqiao, Yi, Yun, Mei, Jiaqi, Liu, Cundong. 2023. Hub gene associated with prognosis in bladder cancer is a novel therapeutic target. In PeerJ, 11, e15670. doi:10.7717/peerj.15670. https://pubmed.ncbi.nlm.nih.gov/37601252/
7. Liu, Chun-Hui, Zhang, Jun-Jie, Zhang, Qian-Jin, Han, Cong-Hui, Hao, Lin. 2023. METTL3 regulates the proliferation, metastasis and EMT progression of bladder cancer through P3H4. In Cellular signalling, 113, 110971. doi:10.1016/j.cellsig.2023.110971. https://pubmed.ncbi.nlm.nih.gov/37979898/
8. Wan, B, Zeng, Q, Tang, X-Z, Tang, Y-X. . P3H4 affects renal carcinoma through up-regulating miR-1/133a. In European review for medical and pharmacological sciences, 22, 5180-5186. doi:10.26355/eurrev_201808_15714. https://pubmed.ncbi.nlm.nih.gov/30178839/
9. Wang, Guixin, Gao, Yukui, Chen, Yanzhuo, Zhang, Shicheng, Li, Gang. 2022. Identification of Novel Tumor Antigens and the Immune Landscapes of Bladder Cancer Patients for mRNA Vaccine Development. In Frontiers in oncology, 12, 921711. doi:10.3389/fonc.2022.921711. https://pubmed.ncbi.nlm.nih.gov/35814377/
10. Mafficini, Andrea, Simbolo, Michele, Shibata, Tatsuhiro, Scarpa, Aldo, Luchini, Claudio. 2022. Integrative characterization of intraductal tubulopapillary neoplasm (ITPN) of the pancreas and associated invasive adenocarcinoma. In Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc, 35, 1929-1943. doi:10.1038/s41379-022-01143-2. https://pubmed.ncbi.nlm.nih.gov/36056133/
智鼠故事 
